Related Experiment Video
Updated: Dec 28, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Epigenetic Marks Repressing Gluconeogenesis in Liver and Kidney Cancer
1Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. katharina.leithner@medunigraz.at.
Abstract:
Gluconeogenesis is frequently suppressed in tumors arising in gluconeogenic organs and reexpression of a gluconeogenesis enzyme, fructose-1,6-bisphosphatase (FBP1), was found to inhibit tumor growth. In this issue of Cancer Research, Liao and colleagues show that histone H3 trimethylation on lysine 27, induced by polycomb repressive complex 2 (PRC2), is responsible for downregulating FBP1 in liver and kidney cancer cells. Moreover, they identified FBP1 repression as an important downstream mechanism of PRC2-mediated carcinogenesis. FBP1 inhibits glycolysis but also directly interferes with PRC2 function, thus FBP1 and PRC2 are part of a novel negative feedback loop that is deregulated in liver and kidney cancer.See related article by Liao et al., p. 675.
Insights
Researchers found that Polycomb Repressive Complex 2 (PRC2) downregulates fructose-1,6-bisphosphatase (FBP1) in liver and kidney cancers. This repression is a key mechanism in cancer development, disrupting a crucial feedback loop.
Area of Science:
- Cancer Biology
- Epigenetics
- Metabolic Regulation
Background:
- Gluconeogenesis is often suppressed in tumors from gluconeogenic organs.
- Re-expression of fructose-1,6-bisphosphatase (FBP1) inhibits tumor growth.
Purpose of the Study:
- To investigate the mechanism of FBP1 downregulation in cancer.
- To identify the role of FBP1 repression in Polycomb Repressive Complex 2 (PRC2)-mediated carcinogenesis.
Main Methods:
- Analysis of histone modifications, specifically H3K27 trimethylation.
- Assessment of FBP1 expression in liver and kidney cancer cells.
- Investigation of the interaction between FBP1 and PRC2.
Main Results:
- PRC2 induces histone H3 trimethylation on lysine 27 (H3K27me3), leading to FBP1 downregulation in liver and kidney cancer cells.
- FBP1 repression is identified as a downstream effect of PRC2 in carcinogenesis.
- FBP1 was found to inhibit glycolysis and directly interfere with PRC2 function.
Conclusions:
- FBP1 and PRC2 form a novel negative feedback loop that is disrupted in liver and kidney cancer.
- PRC2-mediated FBP1 repression is a significant mechanism in cancer development.
- Targeting this feedback loop may offer therapeutic strategies for liver and kidney cancers.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cell Specific Gene Expression
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

